Aspiro Pharma Limited - Company overview

Aspiropharma was incorporated on 5 February 2014 and is registered with ROC Hyderabad.

2014-02-05 Markook, Telangana Active Unlisted Active Compliant
Connect MCP

Key Metrics Public MCA facts are exact. Revenue, profit, assets, and employee figures may show as ranges until unlocked.

REVENUE
₹100–500 Cr
▲ 146.6%
FY 2025
PROFIT / LOSS
₹25–50 Cr
▲ 140.7%
FY 2025
EBITDA
₹50–100 Cr
▲ 261.8%
FY 2025
NET WORTH
₹100–500 Cr
▲ 15.1%
FY 2025
TOTAL ASSETS
₹500–1000 Cr
▲ 35.8%
FY 2025
EMPLOYEE COUNT
401–410
OPEN CHARGES
15
160.02 cr
PAID-UP CAPITAL
1,004.15 cr
AUTHORISED CAPITAL
1,470.10 cr
COMPANY AGE
12 Years 9 Months
since 2014-02-05
LAST FILING WITH ROC
2025-03-31
Last AGM: 2025-07-24
ACTIVE GST
1
Updated: 2023-10-30 19:11:39
TOTAL MONEY RAISED
₹500–1000 Cr
SATISFIED CHARGES
1
46.89 cr

Company Health Scores Scores from 0–100 based on filings, compliance signals, financials, and board history on this profile.

Health scores for Aspiropharma covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.

Vendor Trust Score Low risk
86/100
Overall counterparty comfort for vendors and customers.
  • Blend of compliance (81), financial health (85), director (90) and company-foundation signals.
  • Operating for 12+ years.
Compliance Score Low risk
81/100
Statutory filings, status and regulatory flags.
  • Company status is Active as per MCA.
  • Last balance sheet filed for Mar 2025 - slightly behind.
Financial Health Score Low risk
85/100
Profitability, leverage and liquidity from filed statements.
  • Profitable in FY 2025.
  • Positive net worth.
Director Risk Score Low risk
90/100
Board strength, DIN status and churn.
  • 9 directors on the board.
  • No disqualified or deactivated DINs on the current board.
Scores are derived from MCA filings, financial statements and public records on this page. Higher is safer. They are indicative, not a credit rating.
360° Intelligence Report: trust score, financial health, credit risk, growth & distress signals - auto-generated from filings. View report →

About Aspiropharma Company identity, industry, contact, and registration details from MCA and company records.

Aspiropharma was incorporated on 5 February 2014 and is registered with ROC Hyderabad. It is an active public limited company, now about 12 years old. The registered office is at Plot No. 23, Survey No.321, Biotech Park Phase-Iii, Karkapatla Villa, Markook, Telangana.

In its MCA filings the main business is listed as chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, which made up 100% of turnover.

It has nine directors: Bandi Vamsikrishna, Reddy Narsimha, Srinivas Dakarapu and 6 others. The longest-serving is Bandi Vamsikrishna, on the board since 2014; the most recent to join is Bhaskarreddy Pabbatireddy, appointed in October 2025. 12 former directors are on record; the most recent to leave was Sudhakar Reddy Avuthu in September 2022. Between them, the directors also sit on the boards of 49 other companies, including Aarani Enterprises Private Limited and Allita Finvest And Advisors LLP.

₹1004 crore of its ₹1470 crore authorised capital is paid up (about 68%). Its latest balance sheet on MCA is for the year ending 31 March 2025, and the last AGM was on 24 July 2025. 15 charges (secured loans) are still open, and one more has been paid off.

Pharma ••••••••
  • Location Plot No. 23, Survey No.321, Biotech Park Phase-Iii, Karkapatla Villa, Markook, Telangana - 502281
  • Website aspiropharma.com
Legal NameAspiro Pharma Limited
CIN / LLPINU24100TG2014PLC092771
Company No.092771
ClassificationPublic Limited Indian Non-Government Company
Incorporation Date2014-02-05
Date of AGM2025-07-24
Date of Balance Sheet2025-03-31
Listing StatusUnlisted
ROC CodeRoc Hyderabad
PAN
LEI Number
Active ComplianceActive Compliant

Current Directors of Aspiropharma (9) Current board members from MCA filings, including designation and appointment details.

B
Bandi Vamsikrishna
Director | Since 2014-02-13 | DIN: 01014619
R
Reddy Narsimha
Director | Since 2024-08-03 | DIN: 07850148
S
Srinivas Dakarapu
CFO | Since 2017-06-29
K
Krishnaveni Kura
Director | Since 2017-06-29 | DIN: 07033330
R
Ramaseshappa Siva Prasad Panchangam
Director | Since 2023-08-03 | DIN: 09447160
S
Sudershan Pallap
Company Secretary | Since 2021-04-01

Financial Performance of Aspiropharma Bands and Low / Medium / High trend shape. Exact figures unlock with your report.

Estimated bands · FY 2025
Revenue ₹100–500 Cr ▲ 146.6%
P&L ₹25–50 Cr ▲ 140.7%
EBITDA ₹50–100 Cr ▲ 261.8%
Net worth ₹100–500 Cr ▲ 15.1%

Exact figures and labelled charts require an active report plan.

Verified entity values are shown only after access is granted.

Charges of Aspiropharma Open and satisfied charges registered against the company with MCA.

Others : 205.32 cr
Open Charges: 15 Satisfied Charges: 1
Open 160.02 cr
Satisfied 46.89 cr
LenderAmountStatus
Others
Creation Date: 30 Sep 2024
 100.00 cr Open
Others
Creation Date: 10 May 2024
 9.00 Lakh Open
Others
Creation Date: 03 Apr 2024
 105.00 cr Open

Business Activity Principal business activity and turnover mix from MCA filings.

Activity GroupDescriptionTurnover %
ManufacturingChemical and chemical products, pharmaceuticals, medicinal chemical and botanical products100

Companies With Common Directors Of Aspiropharma Other companies that share directors with this entity, based on MCA and compliance network data.

Board Overlap From MCA / Compliance Filings

Aarani Enterprises Private Limited 1 Shared Director
Allita Finvest And Advisors Llp 1 Shared Director
Anaika Infracon Private Limited 1 Shared Director
Anaika Infraventures Private Limited 1 Shared Director
Anaika Properties Private Limited 1 Shared Director
Anaika Realty Private Limited 1 Shared Director
Aspire Spaces Developers Llp 1 Shared Director
Bandis Investments Private Limited 1 Shared Director
Bheman Infrastructure Private Limited 1 Shared Director
Daaruk Infratech Llp 1 Shared Director
Daksha Land Holdings Llp 1 Shared Director
Dasami Lab Private Limited 1 Shared Director
Editha Infraventures Llp 1 Shared Director
Eliana Investments And Holdings Llp 1 Shared Director
Enkita Hospitality Private Limited 1 Shared Director
Genx Pharma Private Limited 1 Shared Director
Hetero Bio Chemicals Limited 1 Shared Director
Hetero Biopharma Limited 1 Shared Director
Hetero Drugs Limited 1 Shared Director
Hetero Healthcare Limited 1 Shared Director
Hetero Labs Limited 1 Shared Director
Hetero Life Sciences Private Limited 1 Shared Director
Hetero Marbles Private Limited 1 Shared Director
Hetero Plasma Sciences Private Limited 1 Shared Director
Hhc Pharma Llp 1 Shared Director
Honour Infra Estates Limited 1 Shared Director
Honour Lab Limited 1 Shared Director
Honour Synthesis Private Limited 1 Shared Director
Idhant Estate Properties Llp 1 Shared Director
Jagger Infraventures Llp 1 Shared Director
Jurala Organic Farms And Agro Industries Private Limited 1 Shared Director
Kalapa Enterprises Llp 1 Shared Director
Krishn Capital Advisors Llp 1 Shared Director
Multiples Private Equity Fund Ii Llp 1 Shared Director
Paamit Lab Private Limited 1 Shared Director
Ruhika Infraventures Llp 1 Shared Director
Shri Bhramarambikas Industrys Limited 1 Shared Director
Sidhys Services Llp 1 Shared Director
Sri Aditya Dream Homes Llp 1 Shared Director
Sri Aditya Kedia Realtors Llp 1 Shared Director
Sri Mahalakshmi Hyderabad Projects Llp 1 Shared Director
Sri Mahalakshmi Hyderabad Projects Private Limited 1 Shared Director
Sri Sai Karuna Industrys Llp 1 Shared Director
Svs Drugs And Pharmaceuticals Pvt Ltd 1 Shared Director
Tirtarupa Realtors Llp 1 Shared Director
Urania Management & Consultancy Llp 1 Shared Director
Vamsiram Jyothi Developers Llp 1 Shared Director
Vrinda Land Ventures Llp 1 Shared Director
Xiva Heallth Care Private Limited 1 Shared Director

Financial Ratios of Aspiropharma Profitability, leverage, and liquidity ratios from filed statements. Exact values unlock with your report.

11 years of ratios on record

Profitability, leverage and liquidity ratios require an active report plan.

Net profit margin Debt / Equity Current ratio ROE

Unlock exact ratio values and multi-year insights.

Verified entity values are shown only after access is granted.

Shareholding Pattern of Aspiropharma Ownership and contribution detail from filings. Full breakdown unlocks with your report.

10 shareholder categories on record

Ownership mix and contribution history require an active report plan.

Ownership mix Category breakdown Year-wise pattern Promoter holding

Unlock full ownership and contribution details.

Verified entity values are shown only after access is granted.

Employees and EPFO Compliance at Aspiropharma EPFO establishments, contributions, and headcount history. Full records unlock with your report.

1 establishment linked

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

Monthly headcount PF contributions ECR filing status Establishment history

Employee and EPFO history require an active report plan.

Verified entity values are shown only after access is granted.

GST Compliance of Aspiropharma GST registrations and filing status by state. Full compliance detail unlocks with your report.

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

GSTIN registrations State-wise filing status HSN and SAC details Tax jurisdiction records

GST registrations and filing compliance require an active report plan.

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Aspiropharma Ratings, court records, and regulatory alerts. Full risk detail unlocks with your report.

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

Rating history Court and tribunal cases Regulatory alerts Director-linked violations

Credit ratings, litigation, and regulatory alerts require an active report plan.

Verified entity values are shown only after access is granted.

MSME Payment Delays by Aspiropharma MSME supplier payment delays and filing history. Full amounts unlock with your report.

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

Outstanding amounts Delay periods and reasons MSME-1 filing history Vendor payment signals

MSME payment history requires an active report plan.

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Aspiropharma Parent, subsidiary, and related group entities. Full ownership map unlocks with your report.

1 subsidiary on record

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

Parent company Subsidiaries and ownership Associates and joint ventures Entity investments

Corporate group structure requires an active report plan.

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Aspiropharma Official MCA forms, returns, and filing index. Document access unlocks with your report.

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

Incorporation documents Annual returns and statements Charge filings Complete filing index

MCA filings and documents require an active report plan.

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aspiropharma Common questions about this company from MCA and profile data. Some answers are limited until unlocked.
Who is the owner of Aspiropharma?
MCA does not publish an "owner" field. Aspiropharma is run by its directors, Bandi Vamsikrishna, Reddy Narsimha, Srinivas Dakarapu and six others. The people who own the shares are listed in its annual return (form MGT-7), which can differ from the directors.
Who are the current board members and directors of Aspiropharma?
Aspiropharma has nine current directors: Bandi Vamsikrishna (since February 2014), Reddy Narsimha (since August 2024), Srinivas Dakarapu (since June 2017), Krishnaveni Kura (since June 2017), Ramaseshappa Siva Prasad Panchangam (since August 2023) and Sudershan Pallap (since April 2021), plus 3 more.
What is CIN of Aspiropharma?
The CIN of Aspiropharma is U24100TG2014PLC092771. Reading it left to right: U means it is not listed, 24100 is the industry code it registered under, TG is Telangana, 2014 is the year it was registered, PLC is the company type and 092771 is its registration number.
When was Aspiropharma incorporated?
Aspiropharma was incorporated on 5 February 2014 with ROC Hyderabad. That makes it about 12 years old.
What is the registered address of Aspiropharma?
The registered office on MCA records is Plot No. 23, Survey No.321, Biotech Park Phase-Iii, Karkapatla Villa, Markook, Telangana - 502281.
What is the current status of Aspiropharma?
MCA shows Aspiropharma as Active, and its last AGM on record was in July 2025.
What is the contact number or email for Aspiropharma?
You can post to its registered office at Plot No. 23, Survey No.321, Biotech Park Phase-Iii, Karkapatla Villa, Markook, Telangana - 502281 and use its website, https://aspiropharma.com.
What industry or business activity is Aspiropharma associated with?
Its MCA filings list the main business as chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products (100% of turnover).
What is paid-up capital and authorised share capital of Aspiropharma?
Paid-up capital is ₹1004 crore and authorised capital is ₹1470 crore, so about 68% of the authorised amount has been issued.
When did Aspiropharma last file accounts and hold an AGM?
The last AGM on record was on 24 July 2025, and the latest balance sheet is for the year ending 31 March 2025.
Where can I see charges and lenders for Aspiropharma?
15 charges against Aspiropharma are still open and one has been satisfied.
Have any directors left Aspiropharma?
Yes, 12 former directors are on record. The most recent to leave were Sudhakar Reddy Avuthu (September 2022), Chandra Sekhar Tumuluru (November 2021) and Srinivas Vengala (March 2021).
Which companies share directors with Aspiropharma?
49 companies share directors with Aspiropharma. Among them are Aarani Enterprises Private Limited, Allita Finvest And Advisors LLP, Anaika Infracon Private Limited and 46 more.
What is the turnover or revenue of Aspiropharma?
Based on filed financial statements, the revenue of Aspiropharma for FY 2025 was in the ₹100–500 Cr range. That is up 146.6% on the previous year. Exact year-wise revenue, profit and balance sheet figures are on the Financial tab.
What is the net worth of Aspiropharma?
For FY 2025, the net worth of Aspiropharma was in the ₹100–500 Cr range.
How can I get the financial details of Aspiropharma?
The latest accounts on record are for FY 2025. The Financial tab has year-wise profit and loss, balance sheet and ratios, with exact figures after you sign in.
What is the official website of Aspiropharma?
The website on record for Aspiropharma is https://aspiropharma.com.
Which company owns aspiropharma.com?
aspiropharma.com is the website listed for Aspiro Pharma Limited in its company records.
Aspiropharma - is it listed or unlisted?
Aspiropharma is unlisted, so its shares are not traded on a stock exchange. Its CIN starts with U for the same reason.
What is the ROC code of Aspiropharma?
Aspiropharma is registered with ROC Hyderabad.
What is the company classification of Aspiropharma?
MCA classifies Aspiropharma as: Public Limited Indian Non-Government Company.
Does Aspiropharma have subsidiaries?
Yes, one subsidiary is on record for Aspiropharma.
Does Aspiropharma have GST registrations on file?
Yes, one active GST registration is linked to Aspiropharma.

Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.